Novartis reported 2Q26 revenue of $14.4 billion, as strong demand for newer medicines was largely offset by generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results